MDxHealth S.A.
MDXH
Ранг среди акций
#21612
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Цена акции
$3.39
Последняя синхронизация: 2023-12-15
Рыночная капитализация
$96.16M
Изменение (1 день)
-1.73%
Изменение (1 год)
0.01%
Страна
BE
Торговля MDxHealth S.A. (MDXH)
Категория
Healthcare
История цены акций MDxHealth S.A. (MDXH)
Наивысшая цена закрытия: $3.30 2023-12-01
Наименьшая цена закрытия: $109.85 2008-08-01
Наименьшая цена закрытия: $109.85 2008-08-01
История цены акций MDxHealth S.A. с 2008 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $675.88 | 19.16% |
US
|
|
| $229.29 | 5.13% |
US
|
|
| $396.75 | 111.01% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.69 | 19.07% |
US
|
